In this study, we evaluated the anticancer activities of a novel small molecule, NSC765689 (LCC-21), as a target drug for VEGFA/CTNNB1/MMP7/CD44 in CRC (Figure 1). This evidence concerns the gene VEGFA and colorectal carcinoma.